A mucosal adjuvant for the inactivated poliovirus vaccine.
about
An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceAlternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responsesSerum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.Self-replicating alphavirus RNA vaccines.Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.
P2860
A mucosal adjuvant for the inactivated poliovirus vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A mucosal adjuvant for the inactivated poliovirus vaccine.
@en
A mucosal adjuvant for the inactivated poliovirus vaccine.
@nl
type
label
A mucosal adjuvant for the inactivated poliovirus vaccine.
@en
A mucosal adjuvant for the inactivated poliovirus vaccine.
@nl
prefLabel
A mucosal adjuvant for the inactivated poliovirus vaccine.
@en
A mucosal adjuvant for the inactivated poliovirus vaccine.
@nl
P2093
P2860
P1433
P1476
A mucosal adjuvant for the inactivated poliovirus vaccine.
@en
P2093
Benjamin P Steil
Janny Westdijk
Mario Barro
Patricia Jorquera
Robert E Johnston
Wilfried A M Bakker
P2860
P304
P356
10.1016/J.VACCINE.2013.11.101
P407
P577
2013-12-13T00:00:00Z